301520.SZ · 万邦医药
China A-shares · RS rating 97 · As of 2026-10-14
| Price | 62.12 CNY |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 97 / 84 / 97 / 91 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 40 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +87.3% |
| Distance from 52-week high | +29.9% |
| Market cap (USD) | $966.0M |